
OptiCept Technologies AB (publ) develops a technology that controls and applies electrical pulses to optimize various biological processes in Sweden and internationally. The company offers foodtech products, such as juiceCEPT, a c machine; juiceCEPT+, an application for the juice industry; oliveCEPT that deploys a pre-treatment to olive paste in extra virgin olive oil production (EVOO) for better quality of the product and increases extracted EVOO yield; wineCEPT, a technology for the treatment of targets cell membranes in biomass; and dryCEPT to reduce drying time, enhanced flavor, and vivid color on the final dried products. It also provides planttech products, including OptiBoost for cut flowers and OptiBoost for cuttings. The company's products are used for applications in beer, dairy, flowers, food oils, juice, plant milk, and wine. The company was formerly known as OptiFreeze AB (publ) and changed its name to OptiCept Technologies AB (publ) in July 2021. OptiCept Technologies AB (publ) was incorporated in 2011 and is headquartered in Lund, Sweden.
OptiCept Technologies AB (publ) trades as OPTZF on OTC. The company is classified in Industrials / Industrial - Machinery and reports in USD.
The current profile places the business in Industrial - Machinery. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
OptiCept Technologies AB (publ) can be compared against peers such as Aduro Clean Technologies Inc., Agfa-Gevaert N.V., AJIS Co., Ltd., Ceres Global Ag Corp., Chen Hsong Holdings Limited, CB Industrial Product Holding Berhad.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $139.69M, beta of 0.89, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
OPTZF currently shows total debt of N/A and beta of 0.89. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.opticept.se
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.